Details for Patent: 10,329,260
✉ Email this page to a colleague
Which drugs does patent 10,329,260 protect, and when does it expire?
Patent 10,329,260 protects ORLADEYO and is included in one NDA.
This patent has fifty-nine patent family members in twenty-eight countries.
Summary for Patent: 10,329,260
Title: | Human plasma kallikrein inhibitors |
Abstract: | Disclosed are compounds of formula I ##STR00001## as described herein, and pharmaceutically acceptable salts thereof. The compounds are inhibitors of plasma kallikrein. Also disclosed are pharmaceutical compositions comprising at least one such compound, and methods involving use of the compounds and compositions in the treatment and prevention of diseases and conditions characterized by unwanted plasma kallikrein activity. |
Inventor(s): | Kotian; Pravin L. (Hoover, AL), Babu; Yarlagadda S. (Birmingham, AL), Wu; Minwan (Vestavia Hills, AL), Chintareddy; Venkat R. (Vestavia Hills, AL), Kumar; V. Satish (Birmingham, AL), Zhang; Weihe (Vestavia, AL) |
Assignee: | BioCryst Pharmaceuticals, Inc. (Durham, NC) |
Application Number: | 15/977,129 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 10,329,260
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biocryst | ORLADEYO | berotralstat hydrochloride | CAPSULE;ORAL | 214094-001 | Dec 3, 2020 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
Biocryst | ORLADEYO | berotralstat hydrochloride | CAPSULE;ORAL | 214094-002 | Dec 3, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,329,260
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 3113772 | ⤷ Sign Up | 301142 | Netherlands | ⤷ Sign Up |
European Patent Office | 3113772 | ⤷ Sign Up | CA 2021 00040 | Denmark | ⤷ Sign Up |
European Patent Office | 3113772 | ⤷ Sign Up | PA2021524 | Lithuania | ⤷ Sign Up |
European Patent Office | 3113772 | ⤷ Sign Up | LUC00233 | Luxembourg | ⤷ Sign Up |
European Patent Office | 3113772 | ⤷ Sign Up | 2021C/544 | Belgium | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |